Instant access 
 to deep knowledge 
 on biologic drugs 

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-rate plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

BiologicPatentWatch Database Preview

Details for Tradename: TNKASE

« Back to Dashboard

Summary for Tradename: TNKASE

Patents:29
Applicants:1
BLAs:1
Suppliers: see list1

Clinical Trials for: TNKASE

Glossary
Applicant Tradename Ingredient Dosage Form BLA Approval Date Patent No. Assignee Inventors Estimated Patent Expiration (20y From Filing) Status Orphan Source
Genentech
TNKASE
tenecteplase
VIAL103909Jun 02, 20008,430,861 Osprey Medical, Inc. (Eden Prairie, MN) Schwartz; Robert S. (Inver Grove Heights, MN), Van Tassel; Robert A. (Excelsior, MN) <disabled in preview>Active Rxsearch
Genentech
TNKASE
tenecteplase
VIAL103909Jun 02, 20008,377,994 Evonik Degussa GmeH (Essen, DE) Gray; Ann (Hanau, DE), Drechsler; Margarete (Gelnhausen, DE), Hofmann; Ralph (Buchen, DE) <disabled in preview>Active Rxsearch
Genentech
TNKASE
tenecteplase
VIAL103909Jun 02, 20007,815,936 Evonik Degussa GmbH (Essen, DE) Hasenzahl; Steffen (Hanau, DE), Meyer; Jurgen (Stockstadt, DE), Heym; Jurgen (Horstein, DE) <disabled in preview>Active Rxsearch
This preview shows a limited data set.
Subscribe for full access

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: TNKASE

Country Document Number Estimated Expiration
WIPO (PCT)2005032572<disabled in preview>
Brazil0215098<disabled in preview>
Columbia6150188<disabled in preview>
This preview shows a limited data set.
Subscribe for full access

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc